|Bid||14.64 x 0|
|Ask||14.64 x 0|
|Day's Range||14.32 - 14.79|
|52 Week Range||13.53 - 27.88|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||11.18|
|Forward Dividend & Yield||0.96 (5.86%)|
|Ex-Dividend Date||Dec 22, 2021|
|1y Target Est||N/A|
While it was a win for Max Verstappen and Red Bull, the Miami GP was also a big win for Formula 1 and its various teams and sponsors, several of which are large, multinational publicly traded companies which are keen to be associated with the growing U.S. F1 audience.
Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying...
Brazilian lab chain Fleury SA has reached a deal to acquire lab company Marcelo Magalhaes Diagnosticos for 384.5 million reais ($70.12 million), it said in a securities filing on Monday. The deal will increase Fleury's footprint in the Brazilian state of Pernambuco to 31 patient service centers, the company said, adding that Marcelo Magalhaes had a gross revenue of 114 million reais in the 12 months to July 2021. Fleury said the deal implies an EV/EBITDA multiple of 7.5x for 2024, "considering the synergies to be capture after the conclusion of the transaction", which still requires approval from Brazil's antitrust watchdog.